Systemic Lupus Erythematosus A Complex, but Recognizable and Treatable Disease

被引:1
|
作者
Smith, Benjamin J. [1 ]
机构
[1] Florida State Univ, Coll Med, Sch Phys Assistant Practice, 1115 West Call St, Tallahassee, FL 32306 USA
关键词
Systemic lupus erythematosus; Antinuclear antibody; Autoantibodies; Hydroxychloroquine; AMERICAN-COLLEGE; REVISED CRITERIA; PREVALENCE; HYDROXYCHLOROQUINE; CLASSIFICATION; AUTOANTIBODIES; COUNTY; DAMAGE;
D O I
10.1016/j.cpha.2020.08.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SLE is a complex disease that requires a multidisciplinary team to achieve best patient outcomes. Health care providers, including physician assistants, in numerous medical specialties (eg, primary care, rheumatology, dermatology, nephrology, neurology, pulmonology, cardiology) may participate on an individual's health care team based on disease manifestations. Other health professionals are also key. Being a chronic condition, the patient and the provider have the opportunity to work together to choose best treatment and monitoring approaches for best outcomes. Advances have been made in the understanding of the pathophysiology, diagnosis, and treatment of SLE. Additional discovery awaits.
引用
收藏
页码:61 / 73
页数:13
相关论文
共 50 条
  • [41] SYSTEMIC LUPUS ERYTHEMATOSUS - DISEASE IMPACT ON PATIENTS
    Macejova, Zelmira
    Zarikova, Michaela
    Oetterova, Maria
    CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH, 2013, 21 (03) : 171 - 173
  • [42] Bullous skin disease in systemic lupus erythematosus
    Gonzalez Naranjo, Luis Alonso
    Vasquez Duque, Gloria Maria
    Restrepo Escobar, Mauricio
    IATREIA, 2012, 25 (03) : 229 - 239
  • [43] Update on vascular disease in systemic lupus erythematosus
    Kao, AH
    Sabatine, JM
    Manzi, S
    CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (05) : 519 - 527
  • [44] Gastrointestinal and Hepatic Disease in Systemic Lupus Erythematosus
    Brewer, Brian N.
    Kamen, Diane L.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2018, 44 (01) : 165 - +
  • [45] SEVERITY OF KIDNEY DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Tomita, N.
    Mano, S.
    Nakagawa, Y.
    Kanatani, Y.
    VALUE IN HEALTH, 2017, 20 (09) : A492 - A492
  • [46] Mechanisms of disease for the clinician: systemic lupus erythematosus
    Frieri, Marianne
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 110 (04) : 228 - 232
  • [47] Valvular heart disease in systemic lupus erythematosus
    Crawford, MH
    EUROPEAN HEART JOURNAL, 1997, 18 (04) : 535 - 536
  • [48] Systemic lupus erythematosus and Castleman's disease
    Suwannaroj, S
    Elkins, SL
    McMurray, RW
    JOURNAL OF RHEUMATOLOGY, 1999, 26 (06) : 1400 - 1403
  • [49] The spectrum of liver disease in systemic lupus erythematosus
    vanHoek, B
    NETHERLANDS JOURNAL OF MEDICINE, 1996, 48 (06): : 244 - 253
  • [50] Minimal change disease in systemic lupus erythematosus
    Dube, GK
    Markowitz, GS
    Radhakrishnan, J
    Appel, GB
    D'Agati, VD
    CLINICAL NEPHROLOGY, 2002, 57 (02) : 120 - 126